Funding for this research was provided by:
Forskningsrådet om Hälsa, Arbetsliv och Välfärd (2013-0521)
Text and Data Mining valid from 2018-11-28
Received: 21 June 2018
Accepted: 12 November 2018
First Online: 28 November 2018
Ethics approval and consent to participate
: The study was approved by the Regional Ethical Review Board at the University of Gothenburg (Reg. no. 1173-16). Individual consent was not required for the present study. However, all patients have given their informed consent to be included in the Swedish National Diabetes Register.
: Not applicable.
: KAS is employed by AstraZeneca. However, the views expressed in this article are her own and not those of AstraZeneca’s. All other authors declare that they have no competing interests associated with their contribution to the manuscript.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.